Federated Hermes, Inc. Jasper Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.86 $435,435 - $971,550	-251,697 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.96 - $8.01 $2.83 Million - $7.65 Million	-954,880 Reduced 79.14%	251,697 $894,000
Q4 2021 Feb 14, 2022	SELL	$7.21 - $16.42 $2.12 Million - $4.82 Million	-293,423 Reduced 19.56%	1,206,577 $9.47 Million
Q3 2021 Nov 15, 2021	BUY	$9.22 - $15.12 $13.8 Million - $22.7 Million	1,500,000 New	1,500,000 $12.5 Million

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $829M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.